DUBLIN--(BUSINESS WIRE)--The "Generalized Tonic-Clonic Seizure Ongoing Global Clinical Trials Analysis and Outlook" report has been added to ResearchAndMarkets.com's offering. Generalized Tonic-Clonic ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. DENVER — Primary generalized tonic-clonic seizures ...
-- New approval for VIMPAT® (lacosamide) CV in the U.S. as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures (PGTCS) in patients four years of age and older -- All three ...
TOKYO, May 13, 2024 - (JCN Newswire) - - Eisai Co., Ltd. announced today that it has received approval in China for the additional indication of its in-house discovered antiepileptic drug (AED) ...
February 4, 2010 — The US Food and Drug Administration (FDA) has approved an expanded indication for lamotrigine extended-release tablets (Lamictal XR, GlaxoSmithKline) as once-daily adjunctive ...
A phase 3 study assessing the use pregabalin as adjunctive therapy for epilepsy patients 5 to 65 years of age with primary generalized tonic-clonic (PGTC) seizures did not meet its primary endpoint to ...
Credit: Shutterstock. Eprontia is approved for the treatment of partial-onset or primary generalized tonic-clonic seizures and migraine prevention. The Food and Drug Administration (FDA) has approved ...
NeuroPace, Inc. (NASDAQ:NPCE) released preliminary primary endpoint one-year results of the two-year NAUTILUS study evaluating safety and effectiveness of the RNS System for drug-resistant idiopathic ...
The International League Against Epilepsy (ILAE) has revised its classification of seizure types to improve nomenclature, add new seizure types, and give clinicians the ability to classify seizures ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results